Announcement

Collapse
No announcement yet.

Cardiol Rev . Mild to Moderate COVID-19 Infection and Myocarditis: A Review

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cardiol Rev . Mild to Moderate COVID-19 Infection and Myocarditis: A Review


    Cardiol Rev


    . 2022 May 16.
    doi: 10.1097/CRD.0000000000000458. Online ahead of print.
    Mild to Moderate COVID-19 Infection and Myocarditis: A Review


    Eric Bailey 1 , William H Frishman 2



    Affiliations

    Abstract

    The coronavirus disease-2019(COVID-19) pandemic has taken a massive toll on healthcare systems internationally. Severe illness has been seen in a range of patient populations, but those living with cardiovascular disease have suffered to a greater extent, likely because of their comorbidities. In patients with diabetes, hypertension, heart failure and other chronic illnesses, COVID-19 has manifested severe illnesses such as coagulopathies, myocarditis, and arrhythmias, complicating the disease course for those already suffering from underlying illness. There have been numerous studies done exploring the cardiovascular complications of COVID-19. Some of the more concerning findings have revealed a correlation between severe illness and the increasing likelihood for developing cardiovascular manifestations. However, what is more concerning were the studies revealing the presence of myocarditis and other cardiac sequelae in previously healthy patients with mild or asymptomatic COVID-19. The goal of this article is to review the literature to compile information available about whether there is a significant risk of myocarditis in those patients who do not develop severe initial COVID-19 disease.


Working...
X